Lydian Clinic has announced stem cell therapy programs for chronic neurological and inflammatory conditions as interest continues growing around regenerative medicine, minimally invasive care, and advanced treatment technologies available in South Korea.
-- Lydian Cosmetic Surgery Clinic recently announced stem cell therapy services for patients exploring regenerative treatment support for neurodegenerative and autoimmune-related conditions, including Parkinson’s disease and multiple sclerosis. The clinic states that its approach focuses on autologous stem cell therapy designed to support immune regulation, inflammatory response management, and broader regenerative processes associated with chronic neurological conditions.
More information is available at https://www.lydianclinic.com/
The announcement comes at a time when neurological conditions are estimated to affect approximately 43% of the global population, according to findings published in The Lancet Neurology and cited by the World Health Organization. This growing burden has increased global interest in regenerative medicine research exploring how stem cell therapy may support treatment strategies for progressive neurological, vascular, and autoimmune diseases.
Depending on the patients needs, treatment planning may involve stem cells derived from blood, bone marrow, or adipose tissue depending on the patient’s condition and overall health profile. The clinic states that procedures are performed within a Class 10,000 sterile environment, with extraction, separation, and reinjection processes completed onsite as part of broader regenerative therapy protocols.
Lydian Clinic offers stem cell therapy programs for conditions including Parkinson’s disease, multiple sclerosis, Crohn’s disease, arthritis, diabetes, hypertension, hyperlipidemia, and vascular disease. Treatments focus on regenerative cellular therapy designed to support inflammatory regulation and broader tissue recovery associated with chronic degenerative and autoimmune conditions. The clinic describes its approach as focused on supporting damaged tissue and improving regenerative activity through minimally invasive cellular therapy techniques.
South Korea’s growing investment in stem cell research and regenerative medicine infrastructure has also contributed to increased international attention around advanced cellular therapies for chronic disease management. International patients often travel to Seoul for access to specialized regenerative medicine facilities, coordinated care systems, and minimally invasive treatment options within the city’s medical districts.
“Stem cell therapy continues to be studied for its potential role in supporting patients with chronic inflammatory and neurodegenerative conditions,” said Dr. Abraham An. “Treatment planning depends heavily on the patient’s condition, inflammatory profile, and overall health status.”
Individuals interested in learning more about stem cell therapy for neurodegenerative conditions, autoimmune disease support, and regenerative treatment planning can visit https://www.lydianclinic.com/ for additional information and patient guidance.
Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Website: https://www.lydianclinic.com/
Source: NewsNetwork
Release ID: 89192897
In the event of any inaccuracies, problems, or queries arising from the content shared in this press release, we encourage you to notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team will be readily available to respond and take swift action within 8 hours to rectify any identified issues or assist with removal requests. Ensuring the provision of high-quality and precise information is paramount to us.
